Medication-related problems among adult chronic kidney disease patients in a sub-Saharan tertiary hospital
- 131 Downloads
Chronic kidney disease (CKD) patients are prone to medication-related problems (MRPs). Few studies address the clinical relevance of MRPs among CKD patients in sub-Saharan Africa.
To investigate the frequency and predictors of MRPs among adult CKD patients treated at a tertiary care facility in an urban sub-Saharan setting.
Kenyatta National Hospital in Nairobi, Kenya.
A cross-sectional study involving 60 adult patients with CKD was carried out. Data were collected through structured interviews and patient chart reviews between April 2016 and June 2016. MRPs identified from the collected data were classified according to Hepler and Strand classification. The frequencies of the identified MRPs were computed and logistic regression used to investigate the associations between the MRPs and covariates in the data. Main outcome measures: frequencies and predictors of MRPs.
271 MRPs were identified. The commonest MRPs were drug interactions (21.8%), indication without drug (18.1%) and medication non-adherence (15.5%). Compared to patients with CKD stage 3, patients with CKD stage 4 were 5.9 times more likely to have an improper drug selection and 4.7 times more likely to experience overdosage. Other significant predictors of MRPs were the number of medications per prescription and the number of comorbidities per patient.
This study found a high frequency of MRPs among patients with chronic kidney disease receiving care in urban sub-Saharan tertiary hospital settings. The predictors of MRPs among CKD patients in this setting are likely to be multifactorial and include the CKD stage, polypharmacy, and comorbidities.
KeywordsChronic kidney disease Medication-related problems Sub-Saharan Africa Tertiary hospital DRP Kenya
We would like to acknowledge our participants at the Kenyatta National Hospital renal clinic and medical wards. Special thanks to respective matrons.
The study was partially funded by the Kenyatta National Hospital Research and Programs Department and the University of Nairobi. The funding organizations had no role in the design of the study and collection, analysis, and interpretation of data and in writing the manuscript.
Conflicts of interest
The authors (all of them) declare that they have no conflict of interest.
- 2.Schoolwerth AC, Engelgau MM, Hostetter TH, Rufo KH, Chianchiano D, McClellan WM, et al. Chronic kidney disease: a public health problem that needs a public health action plan. Prev Chronic Dis. 2006;3(2):A57-A.Google Scholar
- 3.World Kidney D. Chronic kidney disease: world kidney day; 2015. http://www.worldkidneyday.org/faqs/chronic-kidney-disease/. Accessed on 5th Oct 2016.
- 4.Centers for Disease, Prevention Ca. National chronic kidney disease fact sheet 2014 (1–4). http://www.cdc.gov/diabetes/pubs/factsheets/kidney.htm. Accessed on 12th July 2016.
- 5.Naicker S. Burden of end-stage renal disease in sub-Saharan Africa. Clin Nephrol. 2010;74(Suppl 1):S13–6.Google Scholar
- 14.Rama M, Viswanathan G, Acharya LD, Attur RP, Reddy PN, Raghavan SV. Assessment of drug–drug interactions among renal failure patients of nephrology ward in a South Indian Tertiary Care Hospital; 2012, p. 63–8.Google Scholar
- 19.Kenyatta National H. About Kenyatta National Hospital 2016. http://knh.or.ke/. Accessed on 5th Oct 2016.
- 20.Graffar M. Modern epidemiology; 1971. p. 661–9.Google Scholar
- 21.Daniel W. Biostatistics: a foundation for analysis in the health sciences (10th edition) 1999. 200–3 p. 978-1-118-30279-8.Google Scholar
- 22.Nyakiba JO, Kosgei RJ, Okalebo F. The extent of medication-related problems among patients at Kenyatta National Hospital Medical Wards: A 2012 Study: University of Nairobi; 2014.Google Scholar
- 24.National Kidney F. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, clasification and stratification 2002. S1-S266 p. 1-931472-10-6.Google Scholar
- 25.Drug Interaction Checker (Internet). 2016 (cited 12th April 2016 to 15th July 2016). http://reference.medscape.com/drug-interactionchecker.
- 26.Team RC. R: a language and environment for statistical computing. Vienna: R Foundation for Statistical Computing; 2014.Google Scholar
- 28.Fraser SDS, Roderick PJ, May CR, McIntyre N, McIntyre C, Fluck RJ, et al. The burden of comorbidity in people with chronic kidney disease stage 3: a cohort study. BMC Nephrol. 2015;16(193–03):11p.Google Scholar
- 32.Onyango MA, Okalebo FA, Osanjo GO, Nyamu DG. Patterns of antibiotic use and dose adjustment in patients with chronic kidney disease at Kenyatta National Hospital, Kenya. Pharmacoepidemiol Drug Saf. 2013;22:485.Google Scholar
- 33.Liew Y, Ang S, Kamis HJ, Tan J, Brennan M. Medication compliance and understanding in pre-end stage renal disease. Nephrology. 2010;15:33–4.Google Scholar
- 36.Medication therapy management in pharmacy practice: core elements of an MTM service model (version 2.0). J Am Pharm Assoc JAPhA. 2008;48(3):341–53.Google Scholar